In the present study, we show that RelA/p65 functions as an epithelial tumour promoter in human NSCLC cell lines (harbouring either wild-type or mutant KRAS and TP53 genes) grown as tumour xenografts in immune-compromised NSG mice. Here, KRAS is linked to neoplasm.